EverPoint Asset Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-130,000
Closed -$1.36M 439
2016
Q3
$1.36M Buy
+130,000
New +$1.87M 0.02% 368
2016
Q2
Sell
-100,000
Closed -$1.92M 415
2016
Q1
$1.92M Buy
+100,000
New +$2.02M 0.04% 339
2015
Q3
Sell
-35,000
Closed -$820K 436
2015
Q2
$820K Buy
+35,000
New +$762K 0.02% 419

Other funds holding DVAX

EverPoint Asset Management's DVAX Position: Q4 2016 in Review

EverPoint Asset Management sold out of Dynavax Technologies (DVAX) in Q4 2016, closing a stake of 130,000 shares — an estimated $1.36M sold.

EverPoint Asset Management first reported a position in DVAX in Q2 2015 and held it in 3 quarters. The position peaked at $1.92M in Q1 2016. 111 funds tracked by Wall St. Rank hold DVAX as of Q4 2016.

  • EverPoint Asset Management reported no remaining Dynavax Technologies position as of Q4 2016 after selling out during the quarter.
  • EverPoint Asset Management sold 130,000 Dynavax Technologies shares in Q4 2016, an estimated $1.36M.
  • EverPoint Asset Management first reported a position in Dynavax Technologies in Q2 2015 and held it in 3 quarters.
  • EverPoint Asset Management's Dynavax Technologies position peaked at $1.92M in Q1 2016.
  • 111 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.